Exicure

$1.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.71%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Exicure and other stocks, options, and ETFs commission-free!

About XCUR

Exicure, Inc. Common Stock, also called Exicure, is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. The listed name for XCUR is Exicure, Inc. Common Stock.

CEO
David A. Giljohann
Employees
Headquarters
Skokie, Illinois
Founded
2011
Market Cap
122.99M
Price-Earnings Ratio
Dividend Yield
Average Volume
416.82K
High Today
$1.48
Low Today
$1.40
Open Price
$1.41
Volume
293.30K
52 Week High
$3.84
52 Week Low
$0.9573

Collections

XCUR Earnings

-$0.12
-$0.08
-$0.03
$0.01
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.10 per share

You May Also Like